Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600135060) titled 'Correlation of HER2 Status with 21-Gene Recurrence Score and Biomarker Exploration in HR+/HER2- Early Breast Cancer: A Single-Center Retrospective Cohort Study' on Oct. 23.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)
Condition:
HR+/HER2- Early Breast Cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-25
Target Sample Size: Observation group:600;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=348...